Syndax Pharmaceuticals, Inc.SNDXNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-313.82M
↓ 224% below average
Average (9y)
$-96.81M
Historical baseline
Range
High:$26.87M
Low:$-313.82M
CAGR
+35.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-313.82M | -50.1% |
| 2023 | $-209.14M | -43.1% |
| 2022 | $-146.17M | -644.0% |
| 2021 | $26.87M | +138.2% |
| 2020 | $-70.29M | -26.4% |
| 2019 | $-55.60M | +24.8% |
| 2018 | $-73.88M | -19.4% |
| 2017 | $-61.88M | -41.7% |
| 2016 | $-43.68M | -113.1% |
| 2015 | $-20.49M | - |